3 Reasons Pfizer and BioNTech Will Have Coronavirus Vaccine Data Before Moderna

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) started the phase 3 clinical trial for their coronavirus vaccine BNT162b2 around the same time as Moderna (NASDAQ:MRNA) started its phase 3 study for mRNA-1273.

But all signs point to Pfizer and BioNTech generating faster efficacy data than Moderna. Here's why: